Dr. Reddy's Share Price: Motilal Oswal ne Target Price kiya kam, Investors ko alert!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Dr. Reddy's Share Price: Motilal Oswal ne Target Price kiya kam, Investors ko alert!
Overview

Arre bhaiyo, Dr. Reddy's ke liye ek important update hai. Motilal Oswal ne inke earnings estimates ko kaafi neeche kar diya hai, future earnings ko **25%** tak kam kiya hai FY27-28 ke liye. Rating bhi 'Neutral' hi rakhi hai aur target price ko girakar **₹1,195** kar diya hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Aakhir wajah kya hai is cut ki?

Brokers ka kehna hai ki Dr. Reddy's ke liye g-Revlimid jaise generic products mein competition badh raha hai, jisse profit margins par pressure aa raha hai. Saath hi, semaglutide jaise kuch important products ke launch mein bhi delays ho rahe hain, jo ki Brazil aur Canada mein hone wale the. Generics mein pricing pressure bhi ek bada reason hai. In sab ki wajah se, Motilal Oswal ne future earnings ko kam kar diya hai.

Earnings Estimate mein badi giravat

Reports ke mutabik, FY25 aur FY26 mein earnings thodi slow rahne ki ummeed hai, aur FY27 mein toh aur bhi giravat aa sakti hai kyunki niche products ka rollout slow chal raha hai. Isi wajah se, Motilal Oswal ne FY27 ke liye earnings estimate ko 25% aur FY28 ke liye 8% tak kam kar diya hai.

Naya Target Price aur Valuation

In sab revised forecasts ko dekh kar, Motilal Oswal ne Dr. Reddy's ko 18 times 12-month forward earnings par value kiya hai. Jiske baad company ka naya target price ₹1,195 set kiya gaya hai.

Future Outlook aur Rating

Short term mein situation thodi challenging lag rahi hai, lekin agar b-abatacept jaise kuch niche products ko jaldi regulatory approval mil jata hai, toh FY28 mein earnings ko boost mil sakta hai. Fir bhi, Motilal Oswal ne stock par 'Neutral' rating hi maintain rakhi hai, jo current pressures ko reflect karta hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.